In regard to PHD2, different conclusions had been reached dependent on the cancer type, some indicating PHD2 as either a poor or favorable prognostic factor [37, 43], however, some similar to ours indicating no prognostic significance of PHD2 [39]. The gene discussed is EGLN1; the disease is cancer.